GAMMA Investing’s Heron Therapeutics HRTX Stock Holding History

GAMMA Investing’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.1K	Buy	+9,901	New	+$3.75K	﹤0.01%	3824
2026 Q1	–	Sell	-889	Closed	-$1.16K	–	4174
2025 Q4	$1.16K	Buy	+889	New	+$1.1K	﹤0.01%	3748

Other funds holding HRTX

Apeiron RIA Dallas, Texas $440M AUM 15.34% 1-Year Est. Return

DIM

DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's HRTX Position: Q3 2026 in Review

GAMMA Investing opened a new position in Heron Therapeutics (HRTX) in Q3 2026: 9,901 shares worth $3.1K. The stake represents ﹤0.01% of the portfolio and ranks #3824 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in HRTX as recently as Q4 2025.

GAMMA Investing first reported a position in HRTX in Q4 2025 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

GAMMA Investing held 9,901 shares of Heron Therapeutics worth $3.1K as of Q3 2026.
Heron Therapeutics was a new GAMMA Investing position in Q3 2026.
Heron Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3824 holding.
GAMMA Investing first reported a position in Heron Therapeutics in Q4 2025 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.